Spleen Stiffness Measurement With FibroScan

Exclusion Criteria

• •Patient unable or unwilling to provide written informed consent.
• •Consuming illness (HIV infection, malignancy).
• •Associated comorbidities: NASH, hemochromatosis, primary sclerosing cholangitis, primary biliary cirrhosis.
• •Antiviral treatment during the two months before inclusion.
• •Pacemaker or heart defibrillator.
• •Pregnancy.
• •Liver transplantation.
• •BMI\>35 kg/m2.
• •Serum Transaminases \> 250 IU/L.
• •History of / or current βblockers treatment of OV.
• •Presence of ascites.
• •Previous endoscopic treatment of OV.
• •Patient with acute alcoholic hepatitis and associated jaundice (generally defined by total bilirubin ≥ 50 µmol/l).
• •Patient with hepatocellular carcinoma (HCC).
• •Unable or unwilling to undergo a liver stiffness measurement, a spleen stiffness measurement, an ultrasound examination, a blood examination or a gastroscopy examination.